How Can Clinicians Prevent And Manage Pih In Fractional Laser Resurfacing On Darker Skin?

Clinicians can substantially reduce PIH risk by minimizing thermal injury, controlling inflammation, and enforcing rigorous photoprotection. In darker skin types—particularly Fitzpatrick IV–VI and many Asian skin types—fractional resurfacing should generally use lower fluence, lower microbeam density, fewer passes, and longer intervals between sessions. If PIH occurs, it is often self-limited but should be managed only after the skin has re-epithelialized and active inflammation has resolved.

Core takeaway: Treat darker skin conservatively and progressively. The safest protocol combines careful patient selection, a test patch, reduced treatment intensity, strict UV avoidance, and delayed introduction of pigment-control treatments until the barrier is intact.

Why Fractional Resurfacing Can Cause PIH

The mechanism of pigment formation

Fractional lasers create microscopic columns of thermal injury in the epidermis and dermis to stimulate collagen remodeling. In darker skin, this inflammation can activate melanocytes and increase melanin production, producing PIH during healing.

The risk increases when thermal injury is excessive, inflammation is prolonged, or the patient receives ultraviolet exposure during recovery.

Patient factors that increase risk

Screen for:

Higher Fitzpatrick phototypes, especially IV–VI
A personal history of PIH or dyschromia
Recent tanning or ongoing UV exposure
Active dermatitis, acne, infection, or inflammation
A history of hypertrophic scarring or keloids
High-risk treatment locations such as the neck, chest, and infraorbital region

Do not treat freshly tanned or actively inflamed skin. Stabilize the skin first and postpone treatment when the baseline pigmentary or inflammatory state is uncontrolled.

How to Adjust the Laser Treatment

Use lower fluence and density

Start with lower energy fluence and lower microbeam density than would typically be used for lighter skin. The objective is to create sufficient microscopic injury for clinical improvement without producing unnecessary cumulative heat.

Lower density is particularly important when treating darker phototypes or areas with a history of PIH.

Limit passes and avoid pulse stacking

Use fewer passes and avoid repeatedly treating the same area during one session. Pulse stacking and excessive overlap can create thermal accumulation that increases inflammation, PIH, and scarring risk.

This is especially important on the neck, chest, and infraorbital skin, where healing may be less predictable.

Choose the least aggressive effective modality

When clinically appropriate, non-ablative fractional resurfacing generally preserves more of the epidermal barrier and may have a lower complication burden than ablative treatment.

Ablative fractional treatment can still be considered in selected patients, but it requires more conservative parameters, careful preoperative planning, and stricter aftercare.

Perform a test patch

A preliminary test patch can help assess the patient’s inflammatory and pigmentary response before treating a larger area. Evaluate the test site after an appropriate healing interval rather than assuming that an immediate response predicts the final outcome.

A test patch does not eliminate risk, but it improves decision-making when the patient has a history of PIH or the planned treatment is relatively aggressive.

Favor staged treatment over one aggressive session

A series of conservative treatments is usually safer than attempting to obtain maximal resurfacing in a single session. Extend the interval between sessions sufficiently to allow complete resolution of erythema and inflammation before repeating treatment.

The exact interval should be individualized to the device, treatment depth, treated area, and patient’s recovery.

How to Prepare the Patient

Establish strict photoprotection before treatment

Require broad-spectrum UVA/UVB protection, with sunscreen generally providing at least SPF 30, and emphasize sun avoidance for at least four weeks before and after treatment.

Protection should include hats, shade, avoidance of peak sunlight, and attention to incidental exposure through windows. A patient who cannot reliably follow photoprotection instructions may not be an appropriate candidate at that time.

Stabilize pre-existing pigmentation and inflammation

If the patient has active acne, dermatitis, or another inflammatory condition, manage it before resurfacing. Pre-treatment pigment-control therapy may be appropriate for selected patients, but it should be individualized according to skin sensitivity, prior treatment response, and the planned laser modality.

Hydroquinone or retinoids should not be prescribed automatically to every patient. They can irritate the skin, and irritation itself can increase inflammation and PIH risk.

Set realistic expectations

Explain that fractional resurfacing often requires multiple conservative sessions and that collagen remodeling continues for months. The goal is controlled improvement, not maximal immediate injury.

Patients should understand that temporary darkening can occur during healing and does not necessarily represent permanent pigment alteration.

How to Manage the Immediate Recovery Period

Protect the barrier

After treatment, use gentle cleansing, non-comedogenic moisturization, and the wound-care protocol appropriate for the device and treatment depth. Avoid friction, picking, abrasive products, and unnecessary irritants.

The patient should resume or continue carefully selected photoprotection as soon as it is compatible with the treated skin’s barrier condition and the clinician’s wound-care instructions.

Control inflammation without irritating the skin

Prolonged inflammation increases PIH risk. Manage excessive erythema or inflammatory reactions promptly, using clinician-directed treatment when indicated.

Topical corticosteroids may sometimes be used briefly for significant inflammation, but they should not be used indiscriminately because inappropriate or prolonged use can cause additional cutaneous complications.

Delay depigmenting products until the skin is healed

Do not begin acids, retinoids, hydroquinone, or other potentially irritating agents while the skin is still eroded, markedly erythematous, or incompletely epithelialized.

These products should generally be introduced only after erythema has resolved and the epidermal barrier is stable, because treating too early can create secondary inflammation and worsen pigmentation.

How to Manage PIH if It Develops

Confirm that the pigment is PIH

Post-treatment darkening should be assessed in the context of healing. Consider alternative or additional diagnoses if there is severe pain, blistering, infection, persistent ulceration, unusual scarring, or worsening inflammation.

The management plan should distinguish uncomplicated PIH from an adverse wound-healing response.

Continue rigorous photoprotection

Photoprotection remains the foundation of treatment. Ongoing UVA and UVB exposure can deepen pigmentation and prolong its duration, even when exposure is incidental or occurs through glass.

Use broad-spectrum sunscreen, protective clothing, shade, and behavioral sun avoidance consistently.

Introduce topical lightening therapy cautiously

Once healing is complete, clinicians may consider topical agents such as:

Hydroquinone
Azelaic acid
Kojic acid
Carefully selected glycolic or other mild hydroxy acid preparations

Introduce one active treatment at a time when possible, monitor for irritation, and consider a small-area test before broader application—particularly with hydroquinone or exfoliating agents.

Use mild peels only on fully healed skin

Mild hydroxy acid peels can be considered in selected patients, but they should be conservative and performed only after complete barrier recovery. Overly aggressive peeling can reproduce the inflammation that caused the PIH.

Treatment should be stopped or reduced if burning, dermatitis, or persistent erythema develops.

Understanding the Trade-offs

Lower settings may require more sessions

Reducing fluence, density, and passes lowers the risk of PIH but may also reduce the effect achieved in a single treatment. The practical compromise is often a staged treatment course with reassessment after each session.

More aggressive treatment is not automatically better

Higher energy or density may increase downtime and inflammation without producing proportionally better results. In darker skin, excessive thermal injury can convert a cosmetic treatment into a prolonged pigmentary problem.

Prophylactic agents are not risk-free

Hydroquinone, retinoids, and acids may help control dyschromia, but irritation can worsen PIH. Their timing and use should be based on the patient’s baseline skin condition and the stage of healing rather than applied reflexively.

Ablative treatments require greater caution

Ablative fractional lasers can offer stronger resurfacing, but they generally create a more substantial barrier injury than non-ablative fractional systems. If used in darker skin, conservative settings, careful selection, and close follow-up are essential.

Photoprotection cannot be delegated to sunscreen alone

Sunscreen is important, but adherence also requires shade, hats, clothing, and avoidance of tanning. A patient who continues regular UV exposure can develop or prolong PIH despite appropriate laser settings.

Making the Right Choice for Your Goal

The safest approach is to individualize the protocol and reassess the skin before increasing treatment intensity.

If your primary focus is PIH prevention: Use a test patch, avoid tanned or inflamed skin, reduce fluence and density, limit passes, prevent pulse stacking, and enforce strict UVA/UVB protection before and after treatment.
If your primary focus is acne-scar or wrinkle improvement: Favor a series of conservative sessions with adequate recovery intervals rather than one aggressive treatment.
If your primary focus is treating established PIH: Wait until erythema and epithelial disruption have resolved, then introduce lightening agents or mild peels gradually while maintaining rigorous photoprotection.
If your primary focus is minimizing scarring: Screen for abnormal scarring, use extra caution on the neck and chest, avoid excessive overlap, and monitor healing closely.
If your primary focus is selecting a device: Consider non-ablative fractional resurfacing when it can meet the clinical objective with less barrier disruption and thermal stress.

With conservative treatment parameters, disciplined aftercare, and timely management of inflammation, clinicians can improve resurfacing outcomes while substantially reducing PIH risk in darker skin.

Summary Table:

Strategy	Key Actions
Patient selection	Screen for risk factors (Fitzpatrick IV–VI, PIH history, recent tanning, inflammation)
Laser parameters	Use lower fluence/density, limit passes, avoid pulse stacking
Test patch	Perform a test patch to assess individual response
Staged treatment	Opt for multiple conservative sessions with adequate intervals
Photoprotection	Strict UVA/UVB protection for at least four weeks before and after
Pre-treatment skin prep	Stabilize pigmentation/inflammation, avoid irritants
Post-treatment care	Gentle cleansing, barrier protection, prompt inflammation control
PIH management	Delayed lightening agents until healed, gradual introduction, rigorous photoprotection

Discover safe, effective fractional laser protocols for darker skin with BELIS's advanced systems. Our expert team helps you optimize settings for PIH prevention. Contact us today for tailored solutions!